MDM2 and MDMX bind and stabilize the p53-related protein p73

被引:112
作者
Ongkeko, WM
Wang, XQ
Siu, WY
Lau, AWS
Yamashita, K
Harris, AL
Cox, LS
Poon, RYC [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Peoples R China
[2] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England
[3] Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Imperial Canc Res Fund,Mol Oncol Labs, Oxford OX3 9DU, England
[4] Kanazawa Univ, Fac Pharmaceut Sci, Dept Microbiol, Kanazawa, Ishikawa 920, Japan
关键词
D O I
10.1016/S0960-9822(99)80367-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 gene encodes one of the most important tumor suppressors in human cells and undergoes frequent mutational inactivation in cancers. MDM2, a transcriptional target of p53, binds p53 and can both inhibit p53-mediated transcription [1,2] and target p53 for proteasome-mediated proteolysis [3,4], A close relative of p53, p73, has recently been identified [5,6]. Here, we report that, like p53, p73 alpha and the alternative transcription product p73 beta also bind MDM2, Interaction between MDM2 and p53 represents a key step in the regulation of p53, as MDM2 promotes the degradation of p53. In striking contrast to p53, the half-life of p73 was found to be increased by binding to MDM2, Like MDM2, the MDM2-related protein MDMX also bound p73 and stabilized the level of p73, Moreover, the growth suppression functions of p73 and the induction of endogenous p21, a major mediator of the p53-dependent growth arrest pathway, were enhanced in the presence of MDM2, These differences between the regulation of p53 and p73 by MDM2/MDMX may highlight a physiological difference in their action.
引用
收藏
页码:829 / 832
页数:4
相关论文
共 12 条
[1]  
Ausubel F.M., 1991, CURRENT PROTOCOLS MO
[2]   Inactivation of the p53-homologue p73 by the mdm2-oncoprotein [J].
Dobbelstein, M ;
Wienzek, S ;
König, C ;
Roth, J .
ONCOGENE, 1999, 18 (12) :2101-2106
[3]   TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS [J].
GOSSEN, M ;
BUJARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5547-5551
[4]   Mdm2 promotes the rapid degradation of p53 [J].
Haupt, Y ;
Maya, R ;
Kazaz, A ;
Oren, M .
NATURE, 1997, 387 (6630) :296-299
[5]   p73 is a human p53-related protein that can induce apoptosis [J].
Jost, CA ;
Marin, MC ;
Kaelin, WG .
NATURE, 1997, 389 (6647) :191-194
[6]   Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers [J].
Kaghad, M ;
Bonnet, H ;
Yang, A ;
Creancier, L ;
Biscan, JC ;
Valent, A ;
Minty, A ;
Chalon, P ;
Lelias, JM ;
Dumont, X ;
Ferrara, P ;
McKeon, F ;
Caput, D .
CELL, 1997, 90 (04) :809-819
[7]   Regulation of p53 stability by Mdm2 [J].
Kubbutat, MHG ;
Jones, SN ;
Vousden, KH .
NATURE, 1997, 387 (6630) :299-303
[8]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[9]   ONCOPROTEIN MDM2 CONCEALS THE ACTIVATION DOMAIN OF TUMOR SUPPRESSOR-P53 [J].
OLINER, JD ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
GVURIS, J ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE, 1993, 362 (6423) :857-860
[10]   MDMX: A novel p53-binding protein with some functional properties of MDM2 [J].
Shvarts, A ;
Steegenga, WT ;
Riteco, N ;
vanLaar, T ;
Dekker, P ;
Bazuine, M ;
vanHam, RCA ;
vanOordt, WV ;
Hateboer, G ;
vanderEb, AJ ;
Jochemsen, AG .
EMBO JOURNAL, 1996, 15 (19) :5349-5357